<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1D609091-2855-43FB-AA8A-432F36034898"><gtr:id>1D609091-2855-43FB-AA8A-432F36034898</gtr:id><gtr:name>Pieris AG</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Biology</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1D609091-2855-43FB-AA8A-432F36034898"><gtr:id>1D609091-2855-43FB-AA8A-432F36034898</gtr:id><gtr:name>Pieris AG</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/774D2A5D-D3BA-47D3-BBEF-1D7CFDCB9AB6"><gtr:id>774D2A5D-D3BA-47D3-BBEF-1D7CFDCB9AB6</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Martin</gtr:otherNames><gtr:surname>Kaye</gtr:surname><gtr:orcidId>0000-0002-8796-4755</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0400786"><gtr:id>24619DD9-A39A-4926-86FC-37D7FA943D2B</gtr:id><gtr:title>Immunopathology and the regulation of immune responses during Leishmania donovani infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400786</gtr:grantReference><gtr:abstractText>Single celled parasites, called Leishmania, can be transmitted to humans by biting sand flies and cause a spectrum of diseases collectively known as leishmaniasis. Leishmaniasis is found in 88 countries and some 15M people are infected at any given time. One form of the disease, in which internal organs are affected (visceral leishmaniasis), accounts for approx 100,000 deaths annually, mainly in children. Visceral leishmaniasis occurs predominantly in India, Bangladesh, Nepal, The Sudan and Brazil, but it also occurs in many countries bordering the Mediterranean. The spread of HIV makes visceral leishmaniasis an increasingly important infection. Visceral leishmaniasis is also a severe disease of dogs, with 2-3M dogs infected in Europe alone. Infected dogs help maintain transmission of the disease to man. To understand why people die from this infection, and to help develop new vaccines and drugs for human and veterinary use, it is essential to understand more about how the infection attacks our organs and undermines the immune responses that normally protect us from infection. By studying the nature of the disease in experimental models and how it affects immunity, we shall be able to suggest novel approaches to treatment and aid in effective vaccine design. In addition to publication in peer-reviewed public access journals, the results from this study will be communicated via Outreach activities and by active public relations to disseminate news of important breakthroughs via the local and national press.</gtr:abstractText><gtr:technicalSummary>Visceral leishmaniasis (VL) is a major public health problem in developing countries and there is urgent need to develop new therapeutic approaches to combat active infection and control parasite persistence. Many of the features of human VL can be observed in murine models and experimental VL also provides, in more general terms, a excellent model for studying immune regulation. Notably, the outcome of infection is organ-specific and immune responses are intimately linked to local pathology. Whilst a variety of regulatory pathways have been proposed to control the outcome of infectious disease, these have been poorly characterised to date in VL, and the basis of the regulatory events that lead to chronic infection and parasite persistence represents a major gap in our knowledge. In this proposal, we aim to extend our understanding of immune regulation in experimental VL, building on i) the discovery of a novel pathway by which tissue stromal cells directly regulate the differentiation of dendritic cells with constitutive regulatory function, and ii) the identification of functional and temporal heterogeneity in dendritic cell populations obtained from infected mice. We will make a molecular analysis of stromal cells to identify how they regulate dendritic cell differentiation and to generate novel tools to analyse and manipulate this pathway in vitro and in vivo. We will also make a comprehensive study of the function of regulatory DC and T cells in disease, employing state-of-the-art approaches in cellular immunology (including the use of real time in vivo imaging). Together, these studies will provide essential data on the host response to VL, informing the development of new therapeutics, and provide novel basic information on immunoregulation during parasitic disease.</gtr:technicalSummary><gtr:fund><gtr:end>2010-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1040383</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pieris AG</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>CTLA4 anticalins</gtr:description><gtr:id>CF364453-48A0-4912-83B5-51774776F133</gtr:id><gtr:impact>19416843</gtr:impact><gtr:partnerContribution>Provision of new reagents for future non-contractual research</gtr:partnerContribution><gtr:piContribution>Evaluation of new CTLA4 anticalin as potential immunomodulator for infectious disease</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of York</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biology</gtr:department><gtr:description>Leishmania Functional Genomics</gtr:description><gtr:id>68A06C34-0090-47C9-B2BC-9E1253065864</gtr:id><gtr:impact>19582145 18266814 20300603</gtr:impact><gtr:partnerContribution>generation of new tools and joint publications</gtr:partnerContribution><gtr:piContribution>In depth understanding of murine models of infection required to analyse gene targeted parasites.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>61AF600D-1541-46A2-AD3B-88C35243ECC3</gtr:id><gtr:impact>Approx 60 sixth form students attended a lecture on vaccines for neglected diseases

some follow up with students re career progression</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Teacher course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1F325181-64A4-4766-B820-78CD1B1FE5F8</gtr:id><gtr:impact>Sesion on imaging infectious disease at &amp;quot;How Imaging is Revolutionising Biology&amp;quot; organised by Centre for Immunology and Infection at the National Science and Learning Centre, 17 April 2009

Teacher engagement in modern scientific methodology</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Fair</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1651718B-B0A8-4400-BAF6-BC375CA98540</gtr:id><gtr:impact>Posters, demonstration etc on work of Centre including ongoing research on leishmaniasis

Increased links to schools to develop outreach programme including school visits</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Drama production</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EBC84EE0-0DDB-4E3F-9DE5-33782403B460</gtr:id><gtr:impact>Hosted members of local drama society to develop eductaional production on neglected tropical diseases.

Currently awaiting outcome of Wellcome Trust People Award application.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pump Priming</gtr:description><gtr:end>2010-05-02</gtr:end><gtr:fundingOrg>Yorkshire Cancer Research</gtr:fundingOrg><gtr:id>051B88D6-25A3-4D52-B16C-802863D9E837</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1645567</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust University Translation Award (Therapeutic CD8+ T cell-biased vaccines for human visceral leishmaniasis)</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>425C9D35-6215-4A75-B06C-87E302D5F8D2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (Constitutive migration of alveolar macrophages and the regulation of pulmonary immunity)</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>AFA97B54-120F-40B3-B984-D31F852D5696</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Collaborative production and characterisation of transgeniuc Leishmania</gtr:description><gtr:id>6848C457-F093-48CB-8054-C31C974EA849</gtr:id><gtr:impact>PMID: 19582145 PMID: 19036811 PMID: 18266814 PMID: 16818747</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Transgenic parasites</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19582145</gtr:url><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Whole genome gene expression profiling of cells infecetd or not with Leishmania</gtr:description><gtr:id>3C73B943-9458-4652-878D-AE079BE0AE9F</gtr:id><gtr:impact>Plos Pathogens in press J. Immunol, submitted</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Macrophage and stromal cell expression profiling</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5109AEA1-9DD7-4EBB-9A03-D2FFAE1BDD60"><gtr:id>5109AEA1-9DD7-4EBB-9A03-D2FFAE1BDD60</gtr:id><gtr:title>Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/428645063616f6d3fcc37a153726e878"><gtr:id>428645063616f6d3fcc37a153726e878</gtr:id><gtr:otherNames>de Souza JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6006E098-A909-41E4-9BC6-170B79C7DD50"><gtr:id>6006E098-A909-41E4-9BC6-170B79C7DD50</gtr:id><gtr:title>Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Ra-responsive macrophages and neutrophils.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7b119db49b9d6b190ff3a600c1203a"><gtr:id>1e7b119db49b9d6b190ff3a600c1203a</gtr:id><gtr:otherNames>McFarlane E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/38C1C594-2FA0-4DE8-97BD-42114227099C"><gtr:id>38C1C594-2FA0-4DE8-97BD-42114227099C</gtr:id><gtr:title>Antigen-experienced T cells limit the priming of naive T cells during infection with Leishmania major.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2dbad61381f30bd8142c0a4c7744c3e"><gtr:id>c2dbad61381f30bd8142c0a4c7744c3e</gtr:id><gtr:otherNames>Gray PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97CF02FE-46AE-4C29-A243-91B343EE5FA7"><gtr:id>97CF02FE-46AE-4C29-A243-91B343EE5FA7</gtr:id><gtr:title>VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d5c3c61b5b0f65d9dbb4256db8c9a59"><gtr:id>0d5c3c61b5b0f65d9dbb4256db8c9a59</gtr:id><gtr:otherNames>Stanley AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B9722F3-4E2D-4ED2-BEFC-D1D41B28203E"><gtr:id>2B9722F3-4E2D-4ED2-BEFC-D1D41B28203E</gtr:id><gtr:title>Visceral leishmaniasis: immunology and prospects for a vaccine.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7c89aed5fb181cf2634c915b0d4e12c9"><gtr:id>7c89aed5fb181cf2634c915b0d4e12c9</gtr:id><gtr:otherNames>Kaye PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/61B02D44-03BB-4E17-9B5A-71F97CE9CE81"><gtr:id>61B02D44-03BB-4E17-9B5A-71F97CE9CE81</gtr:id><gtr:title>Alveolar macrophages transport pathogens to lung draining lymph nodes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dde8be5a082ff95a64e9f3cf7f9b6771"><gtr:id>dde8be5a082ff95a64e9f3cf7f9b6771</gtr:id><gtr:otherNames>Kirby AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/51E71E2E-4FEE-46A2-8BEC-919B1598E708"><gtr:id>51E71E2E-4FEE-46A2-8BEC-919B1598E708</gtr:id><gtr:title>Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d5c3c61b5b0f65d9dbb4256db8c9a59"><gtr:id>0d5c3c61b5b0f65d9dbb4256db8c9a59</gtr:id><gtr:otherNames>Stanley AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F830AA6A-1169-4FDF-94B2-1C9200BEF84F"><gtr:id>F830AA6A-1169-4FDF-94B2-1C9200BEF84F</gtr:id><gtr:title>Transgenic Leishmania and the immune response to infection.</gtr:title><gtr:parentPublicationTitle>Parasite immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f74cb360370ab50a1ef10a822c94104"><gtr:id>3f74cb360370ab50a1ef10a822c94104</gtr:id><gtr:otherNames>Beattie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0141-9838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9AD931C4-0582-4DD8-B1CD-E6BAB10A2CE9"><gtr:id>9AD931C4-0582-4DD8-B1CD-E6BAB10A2CE9</gtr:id><gtr:title>Stromal cell induction of regulatory dendritic cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dc84d5bfd6bb01e33e7e4cac6e581f8f"><gtr:id>dc84d5bfd6bb01e33e7e4cac6e581f8f</gtr:id><gtr:otherNames>Owens BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E91C556-BCAC-476E-80E8-16DA625330EB"><gtr:id>1E91C556-BCAC-476E-80E8-16DA625330EB</gtr:id><gtr:title>Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7c1e981cf0ad0791f89b1e058b68e72f"><gtr:id>7c1e981cf0ad0791f89b1e058b68e72f</gtr:id><gtr:otherNames>Rowe HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA2AB37B-5915-49AC-9C89-9383CA020A78"><gtr:id>DA2AB37B-5915-49AC-9C89-9383CA020A78</gtr:id><gtr:title>Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f74cb360370ab50a1ef10a822c94104"><gtr:id>3f74cb360370ab50a1ef10a822c94104</gtr:id><gtr:otherNames>Beattie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92D42A10-BC5F-4F1C-9229-D5F4C63D49D3"><gtr:id>92D42A10-BC5F-4F1C-9229-D5F4C63D49D3</gtr:id><gtr:title>Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f74cb360370ab50a1ef10a822c94104"><gtr:id>3f74cb360370ab50a1ef10a822c94104</gtr:id><gtr:otherNames>Beattie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99B34390-D021-4F00-833D-4D36F6E3956F"><gtr:id>99B34390-D021-4F00-833D-4D36F6E3956F</gtr:id><gtr:title>Lessons from other diseases: granulomatous inflammation in leishmaniasis.</gtr:title><gtr:parentPublicationTitle>Seminars in immunopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7c89aed5fb181cf2634c915b0d4e12c9"><gtr:id>7c89aed5fb181cf2634c915b0d4e12c9</gtr:id><gtr:otherNames>Kaye PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1863-2297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/305C2E4D-DA03-4F1E-A692-DF0D1D2CB737"><gtr:id>305C2E4D-DA03-4F1E-A692-DF0D1D2CB737</gtr:id><gtr:title>Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/64f36726b2fdda200dbb3275feba4d5c"><gtr:id>64f36726b2fdda200dbb3275feba4d5c</gtr:id><gtr:otherNames>Yurdakul P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1DA55F2F-F5B6-437C-9B15-00054B2AA70E"><gtr:id>1DA55F2F-F5B6-437C-9B15-00054B2AA70E</gtr:id><gtr:title>Leishmaniasis: complexity at the host-pathogen interface.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14a4d75bdfa47b148a6a4d1e5f14c5bc"><gtr:id>14a4d75bdfa47b148a6a4d1e5f14c5bc</gtr:id><gtr:otherNames>Kaye P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74F96E87-091E-4EF0-948A-C26EE7AFFFE9"><gtr:id>74F96E87-091E-4EF0-948A-C26EE7AFFFE9</gtr:id><gtr:title>Leishmania donovani-induced expression of signal regulatory protein alpha on Kupffer cells enhances hepatic invariant NKT-cell activation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f74cb360370ab50a1ef10a822c94104"><gtr:id>3f74cb360370ab50a1ef10a822c94104</gtr:id><gtr:otherNames>Beattie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB677D18-7A7E-4EA5-A9B5-EFFB08A092E1"><gtr:id>EB677D18-7A7E-4EA5-A9B5-EFFB08A092E1</gtr:id><gtr:title>IRF7 regulates TLR2-mediated activation of splenic CD11c(hi) dendritic cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dc84d5bfd6bb01e33e7e4cac6e581f8f"><gtr:id>dc84d5bfd6bb01e33e7e4cac6e581f8f</gtr:id><gtr:otherNames>Owens BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F0A5A51-D438-4D14-B6B8-DC437C0BAA1F"><gtr:id>3F0A5A51-D438-4D14-B6B8-DC437C0BAA1F</gtr:id><gtr:title>Stromal-cell regulation of dendritic-cell differentiation and function.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c2157d506b352ffe7ff0e8305d2b84f9"><gtr:id>c2157d506b352ffe7ff0e8305d2b84f9</gtr:id><gtr:otherNames>Svensson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/074C2E5C-5164-4DB5-A644-48FF27EB2D4E"><gtr:id>074C2E5C-5164-4DB5-A644-48FF27EB2D4E</gtr:id><gtr:title>SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophages.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dde8be5a082ff95a64e9f3cf7f9b6771"><gtr:id>dde8be5a082ff95a64e9f3cf7f9b6771</gtr:id><gtr:otherNames>Kirby AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68E2653A-27B6-4A5F-93A6-16C1286C9E71"><gtr:id>68E2653A-27B6-4A5F-93A6-16C1286C9E71</gtr:id><gtr:title>Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/21596ab2a933d8028a3e2b1d1dd45a02"><gtr:id>21596ab2a933d8028a3e2b1d1dd45a02</gtr:id><gtr:otherNames>Polley R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/70772171-E2F8-44F1-9562-6A67A9D3010F"><gtr:id>70772171-E2F8-44F1-9562-6A67A9D3010F</gtr:id><gtr:title>Leishmania-host interactions: what has imaging taught us?</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f74cb360370ab50a1ef10a822c94104"><gtr:id>3f74cb360370ab50a1ef10a822c94104</gtr:id><gtr:otherNames>Beattie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50832B9A-7757-4635-8C06-AC23ECB1E4E9"><gtr:id>50832B9A-7757-4635-8C06-AC23ECB1E4E9</gtr:id><gtr:title>Dendritic cells matured by inflammation induce CD86-dependent priming of naive CD8+ T cells in the absence of their cognate peptide antigen.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f90ac9a971753de9cffe88e2eafa0a30"><gtr:id>f90ac9a971753de9cffe88e2eafa0a30</gtr:id><gtr:otherNames>Maroof A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20D402FC-998D-4A05-A973-779FCF6B3BB2"><gtr:id>20D402FC-998D-4A05-A973-779FCF6B3BB2</gtr:id><gtr:title>Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7b016fb6b1088ac1954c5f10150b029"><gtr:id>d7b016fb6b1088ac1954c5f10150b029</gtr:id><gtr:otherNames>Dalton JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA62A59C-51F9-4520-AAAD-01A9F0AC2D76"><gtr:id>FA62A59C-51F9-4520-AAAD-01A9F0AC2D76</gtr:id><gtr:title>Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad7dc2e55cb41a87687d9d8c7a003766"><gtr:id>ad7dc2e55cb41a87687d9d8c7a003766</gtr:id><gtr:otherNames>Phillips R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE6F271D-31F8-4532-A626-62B4D152EE05"><gtr:id>DE6F271D-31F8-4532-A626-62B4D152EE05</gtr:id><gtr:title>Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14baf4dd24a0e092ff65144203abe4a3"><gtr:id>14baf4dd24a0e092ff65144203abe4a3</gtr:id><gtr:otherNames>Ato M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/02E921C2-3F9B-45C9-A4FA-A8D14B473432"><gtr:id>02E921C2-3F9B-45C9-A4FA-A8D14B473432</gtr:id><gtr:title>Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c mice.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/627fe3f5c5083a1e7dad400696d97ed9"><gtr:id>627fe3f5c5083a1e7dad400696d97ed9</gtr:id><gtr:otherNames>Schroeder J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF0BBDBF-69C9-4EDF-B43B-1CBA773F13F9"><gtr:id>DF0BBDBF-69C9-4EDF-B43B-1CBA773F13F9</gtr:id><gtr:title>IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c? cell populations during visceral leishmaniasis.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dc84d5bfd6bb01e33e7e4cac6e581f8f"><gtr:id>dc84d5bfd6bb01e33e7e4cac6e581f8f</gtr:id><gtr:otherNames>Owens BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E60503F6-B1DE-44DD-8A55-B9B44443DA51"><gtr:id>E60503F6-B1DE-44DD-8A55-B9B44443DA51</gtr:id><gtr:title>Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f90ac9a971753de9cffe88e2eafa0a30"><gtr:id>f90ac9a971753de9cffe88e2eafa0a30</gtr:id><gtr:otherNames>Maroof A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C5788CF9-DB10-4998-95B0-2D39396E4BD6"><gtr:id>C5788CF9-DB10-4998-95B0-2D39396E4BD6</gtr:id><gtr:title>Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fda7e76db5f7d7451739cb5be257d77f"><gtr:id>fda7e76db5f7d7451739cb5be257d77f</gtr:id><gtr:otherNames>St?ger S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7408D4A2-CF72-441F-84F7-CD04009078D8"><gtr:id>7408D4A2-CF72-441F-84F7-CD04009078D8</gtr:id><gtr:title>Comparative expression profiling of Leishmania: modulation in gene expression between species and in different host genetic backgrounds.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03f50fdda9533c73c407c979b78d57e2"><gtr:id>03f50fdda9533c73c407c979b78d57e2</gtr:id><gtr:otherNames>Depledge DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F478D162-6BCE-4AEA-A7A1-10EC9917AB5D"><gtr:id>F478D162-6BCE-4AEA-A7A1-10EC9917AB5D</gtr:id><gtr:title>An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02cc83f01768552229704a1456124032"><gtr:id>02cc83f01768552229704a1456124032</gtr:id><gtr:otherNames>Sch?nfeld D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E7A33C5A-063D-4B01-B154-50E97A793F99"><gtr:id>E7A33C5A-063D-4B01-B154-50E97A793F99</gtr:id><gtr:title>B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e3e7405347d7549210cf6f7e01ad666b"><gtr:id>e3e7405347d7549210cf6f7e01ad666b</gtr:id><gtr:otherNames>Moore JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3795D958-F9E8-4453-AEAA-6F75DBFD1130"><gtr:id>3795D958-F9E8-4453-AEAA-6F75DBFD1130</gtr:id><gtr:title>Vaccines for the leishmaniases: proposals for a research agenda.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/024baeec1a066e4ad8fbefc524452bdc"><gtr:id>024baeec1a066e4ad8fbefc524452bdc</gtr:id><gtr:otherNames>Working Group on Research Priorities for Development of Leishmaniasis Vaccines</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C91E709-EDE2-4231-9919-8FA2E1B588D6"><gtr:id>0C91E709-EDE2-4231-9919-8FA2E1B588D6</gtr:id><gtr:title>In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localization.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8608fcf3cdf9a61a08b4f4fcd8c73477"><gtr:id>8608fcf3cdf9a61a08b4f4fcd8c73477</gtr:id><gtr:otherNames>Prickett S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5A90956-3B88-4CC5-A66A-B66C43E0FD53"><gtr:id>A5A90956-3B88-4CC5-A66A-B66C43E0FD53</gtr:id><gtr:title>The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53f72d8831981101fe5554af718c8cca"><gtr:id>53f72d8831981101fe5554af718c8cca</gtr:id><gtr:otherNames>Hassan MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E6304DE-CB28-4C31-A7FA-73676A479F81"><gtr:id>8E6304DE-CB28-4C31-A7FA-73676A479F81</gtr:id><gtr:title>Postgenomic research on leishmaniasis: a critical self-appraisal.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7c89aed5fb181cf2634c915b0d4e12c9"><gtr:id>7c89aed5fb181cf2634c915b0d4e12c9</gtr:id><gtr:otherNames>Kaye PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5B16C147-4D12-4FA7-99F0-9CD137D03681"><gtr:id>5B16C147-4D12-4FA7-99F0-9CD137D03681</gtr:id><gtr:title>Immunomodulators: use in combined therapy against leishmaniasis.</gtr:title><gtr:parentPublicationTitle>Expert review of anti-infective therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7b016fb6b1088ac1954c5f10150b029"><gtr:id>d7b016fb6b1088ac1954c5f10150b029</gtr:id><gtr:otherNames>Dalton JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1478-7210</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C1F1E11F-A94D-469A-BB8A-9D9024974DEF"><gtr:id>C1F1E11F-A94D-469A-BB8A-9D9024974DEF</gtr:id><gtr:title>Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f90ac9a971753de9cffe88e2eafa0a30"><gtr:id>f90ac9a971753de9cffe88e2eafa0a30</gtr:id><gtr:otherNames>Maroof A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E57DDCC5-7615-4E71-8E79-77CB10704F19"><gtr:id>E57DDCC5-7615-4E71-8E79-77CB10704F19</gtr:id><gtr:title>Stromal cell-derived CXCL12 and CCL8 cooperate to support increased development of regulatory dendritic cells following Leishmania infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f360721c1e1c85e5155edea6f39b4c3f"><gtr:id>f360721c1e1c85e5155edea6f39b4c3f</gtr:id><gtr:otherNames>Nguyen Hoang AT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400786</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>